JP2008542386A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008542386A5 JP2008542386A5 JP2008514814A JP2008514814A JP2008542386A5 JP 2008542386 A5 JP2008542386 A5 JP 2008542386A5 JP 2008514814 A JP2008514814 A JP 2008514814A JP 2008514814 A JP2008514814 A JP 2008514814A JP 2008542386 A5 JP2008542386 A5 JP 2008542386A5
- Authority
- JP
- Japan
- Prior art keywords
- och
- conh
- aryl
- chco
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68658505P | 2005-06-02 | 2005-06-02 | |
| US60/686,585 | 2005-06-02 | ||
| PCT/US2006/021142 WO2006130707A2 (en) | 2005-06-02 | 2006-06-01 | Mao-b inhibitors useful for treating obesity |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008542386A JP2008542386A (ja) | 2008-11-27 |
| JP2008542386A5 true JP2008542386A5 (OSRAM) | 2012-07-12 |
| JP5253155B2 JP5253155B2 (ja) | 2013-07-31 |
Family
ID=37482280
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008514814A Expired - Fee Related JP5253155B2 (ja) | 2005-06-02 | 2006-06-01 | 肥満治療に有用なｍａｏ−ｂ阻害剤 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US7649115B2 (OSRAM) |
| EP (1) | EP1890690A4 (OSRAM) |
| JP (1) | JP5253155B2 (OSRAM) |
| CN (1) | CN101300006B (OSRAM) |
| AU (1) | AU2006252540B2 (OSRAM) |
| CA (1) | CA2620476A1 (OSRAM) |
| IL (1) | IL187825A (OSRAM) |
| NZ (1) | NZ564130A (OSRAM) |
| WO (1) | WO2006130707A2 (OSRAM) |
| ZA (1) | ZA200800036B (OSRAM) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI361075B (en) * | 2007-03-16 | 2012-04-01 | Brion Res Inst Of Taiwan | Pharmaceutical composition for inhibiting the syndrome of snore |
| EP2053033A1 (en) * | 2007-10-26 | 2009-04-29 | Bayer Schering Pharma AG | Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors |
| IT1392914B1 (it) * | 2009-01-22 | 2012-04-02 | Dipharma Francis Srl | Procedimento per la preparazione di (r)-n-propargil-1-amminoindano e suoi sali |
| KR102007633B1 (ko) | 2016-12-15 | 2019-08-06 | 일동제약(주) | 신규 페닐 프로피온 산 유도체 및 이의 용도 |
| CN107056630B (zh) * | 2017-01-23 | 2020-01-17 | 合肥工业大学 | 一种茚满类衍生物及其合成方法和在医药上的用途 |
| IL273428B2 (en) | 2017-09-22 | 2023-09-01 | Jubilant Epipad LLC | Heterocyclic compounds as pad inhibitors |
| CN111225915B (zh) | 2017-10-18 | 2023-03-07 | 朱比兰特埃皮帕德有限公司 | 作为pad抑制剂的咪唑并吡啶化合物 |
| BR112020008851A2 (pt) | 2017-11-06 | 2020-10-20 | Jubilant Prodel LLC | composto da fórmula i, processo de preparação de compostos da fórmula i, composição farmacêutica, método para o tratamento e/ou prevenção de várias doenças, uso, método para o tratamento de câncer, método de tratamento de câncer e método para o tratamento e/ou prevenção de câncer e doenças infecciosas |
| JP7368369B2 (ja) | 2017-11-24 | 2023-10-24 | ジュビラント・エピスクライブ・エルエルシー | Ｐｒｍｔ５阻害剤としてのヘテロ環式化合物 |
| JP7279063B6 (ja) | 2018-03-13 | 2024-02-15 | ジュビラント プローデル エルエルシー | Ｐｄ１／ｐｄ－ｌ１相互作用／活性化の阻害剤としての二環式化合物 |
| EP4358958A1 (en) * | 2021-06-21 | 2024-05-01 | Yunovia, Co., Ltd. | Method of controlling blood sugar level and treatment of diabetes and related conditions |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3201470A (en) * | 1965-08-17 | Chsx c cech | ||
| US3253037A (en) * | 1962-06-19 | 1966-05-24 | Ciba Geigy Corp | N-2-alkynyl-amino-benzocylo-alkanes |
| GB1187017A (en) * | 1966-07-16 | 1970-04-08 | Aspro Nicholas Ltd | Substituted 1-Amino Indanes and Tetrahydronaphthalens |
| IL92952A (en) * | 1990-01-03 | 1994-06-24 | Teva Pharma | R-enantiomers of n-propargyl-1-aminoindan compounds, their preparation and pharmaceutical compositions containing them |
| IL112819A (en) * | 1991-10-16 | 2001-11-25 | Teva Pharma | Fluorinated 1-aminoindan compounds and a process for their preparation |
| US5877218A (en) * | 1994-01-10 | 1999-03-02 | Teva Pharmaceutical Industries, Ltd. | Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives |
| ZA96211B (en) | 1995-01-12 | 1996-07-26 | Teva Pharma | Compositions containing and methods of using 1- aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives |
| DE69738275T2 (de) * | 1996-12-18 | 2008-08-28 | Teva Pharmaceutical Industries Ltd. | Aminoindanderivate |
| EP1078632A1 (en) * | 1999-08-16 | 2001-02-28 | Sanofi-Synthelabo | Use of monoamine oxydase inhibitors for the manufacture of drugs intended for the treatment of obesity |
| DE10142667B4 (de) * | 2001-08-31 | 2004-06-09 | Aventis Pharma Deutschland Gmbh | C2-substituierte Indan-1-ole und ihre Derivate und ihre Verwendung als Arzneimittel |
| CA2467337A1 (en) * | 2001-12-21 | 2003-07-10 | H. Lundbeck A/S | Aminoindane derivatives as serotonin and norepinephrine uptake inhibitors |
| US20040010038A1 (en) * | 2002-02-27 | 2004-01-15 | Eran Blaugrund | Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective MAO inhibitors |
| EP1490324A4 (en) | 2002-02-27 | 2007-10-10 | Teva Pharma | PROPARGYLAMINOINDANE DERIVATIVES AND PROPARGYLAMINOTETRALIN DERIVATIVES AS BRAIN-LIKE MAO INHIBITORS |
| EP2433626B1 (en) * | 2003-11-25 | 2015-11-04 | Technion Research & Development Foundation Ltd. | Compositions and methods for treatment of cardiovascular disorders and diseases |
| WO2005084205A2 (en) * | 2004-02-27 | 2005-09-15 | Teva Pharmaceutical Industries, Ltd. | Diamino thiazoloindan derivatives and their use |
| US20050197365A1 (en) * | 2004-02-27 | 2005-09-08 | Jeffrey Sterling | Diamino thiazoloindan derivatives and their use |
| WO2006120577A1 (en) * | 2005-02-22 | 2006-11-16 | Teva Pharmaceutical Industries Ltd. | Improved process for the synthesis of enantiomeric indanylamine derivatives |
-
2006
- 2006-06-01 NZ NZ564130A patent/NZ564130A/en not_active IP Right Cessation
- 2006-06-01 AU AU2006252540A patent/AU2006252540B2/en not_active Ceased
- 2006-06-01 EP EP06771748A patent/EP1890690A4/en not_active Withdrawn
- 2006-06-01 JP JP2008514814A patent/JP5253155B2/ja not_active Expired - Fee Related
- 2006-06-01 CA CA002620476A patent/CA2620476A1/en not_active Abandoned
- 2006-06-01 WO PCT/US2006/021142 patent/WO2006130707A2/en not_active Ceased
- 2006-06-01 CN CN2006800273036A patent/CN101300006B/zh not_active Expired - Fee Related
- 2006-06-01 US US11/445,044 patent/US7649115B2/en not_active Expired - Fee Related
-
2007
- 2007-12-02 IL IL187825A patent/IL187825A/en not_active IP Right Cessation
-
2008
- 2008-01-02 ZA ZA200800036A patent/ZA200800036B/xx unknown
-
2009
- 2009-12-31 US US12/650,642 patent/US8541475B2/en not_active Expired - Fee Related